SL

Sylvaine Lafont

AS Aventis Pharma S.A.: 2 patents #201 of 591Top 35%
BO BOE: 2 patents #5,928 of 12,373Top 50%
ME Merial: 1 patents #200 of 414Top 50%
SA Sanofi: 1 patents #1,013 of 1,881Top 55%
📍 Yssingeaux, FR: #22 of 146 inventorsTop 20%
Overall (All Time): #825,668 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11130739 Crystalline forms of (S)-afoxolaner Roelof Johannes Gorter de Vries, Bruno Baillon, Myriam Gay de Saint Michel, Stephane Kozlovic 2021-09-28
10662163 Crystalline forms of (S)-afoxolaner Roelof Johannes Gorter de Vries, Bruno Baillon, Myriam Gay de Saint Michel, Stephane Kozlovic 2020-05-26
10433552 Process for the preparation of isoxazoline compounds Chunhua Yang, Loic Patrick Le Hir de Fallois, Charles Q. Meng, Alan Long, Roelof Johannes Gorter de Vries +3 more 2019-10-08
8461312 Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives Guenter Billen, Wendelin Frick, John P. Larkin, Guy Lemaitre, Francoise Bendetti +5 more 2013-06-11
6982334 Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid Jacques Bourget, Marc-Antoine Perrin, Serge Mignani, Bernd Janocha, Michel Cheve +3 more 2006-01-03
6939970 Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6 methoxyquinolin-4-propyl]-1-[2-2-thienylthio)ethyl] piperidine-3-carboxylic acid Jacques Bourget, Marc-Antoine Perrin, Bernd Janocha, Carole Neves, Pascal Billot 2005-09-06